AIM IMMUNOTECH INC. Gain (Loss) on Investments
AIM IMMUNOTECH INC. (AIM) reported Gain (Loss) on Investments of -$1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2026-08-07
- AIM IMMUNOTECH INC. gain (loss) on investments for the quarter ending 2026-06-30 was -$1.00K.
- AIM IMMUNOTECH INC. gain (loss) on investments for the quarter ending 2026-03-31 was -$1.00K, a 103.70% decline year-over-year.
- AIM IMMUNOTECH INC. gain (loss) on investments for the quarter ending 2025-12-31 was $0.00.
- AIM IMMUNOTECH INC. gain (loss) on investments for the quarter ending 2025-09-30 was -$1.00K, a 100.37% decline year-over-year.
- AIM IMMUNOTECH INC. gain (loss) on investments for fiscal 2025 was $17.00K.
- AIM IMMUNOTECH INC. gain (loss) on investments for fiscal 2024 was -$93.00K, a 146.50% decline from fiscal 2023.
- AIM IMMUNOTECH INC. gain (loss) on investments for fiscal 2023 was $200.00K.
- AIM IMMUNOTECH INC. gain (loss) on investments for fiscal 2022 was -$1.68M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.00K 10-Q · filed 2026-08-07 | -$2.00K 10-Q · filed 2026-08-07 | -$2.00K derived: sum of 3 quarters · filed 2026-08-07 | -$3.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$1.00K 10-Q · filed 2026-05-15 | -$1.00K derived: sum of 2 quarters · filed 2026-05-15 | -$2.00K derived: sum of 3 quarters · filed 2026-05-15 | -$11.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$1.00K derived: sum of 2 quarters · filed 2026-03-27 | -$10.00K derived: sum of 3 quarters · filed 2026-08-07 | $17.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | -$1.00K 10-Q · filed 2025-11-17 | -$10.00K derived: sum of 2 quarters · filed 2026-08-07 | $17.00K 10-Q · filed 2025-11-17 | -$172.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$9.00K 10-Q · filed 2026-08-07 | $18.00K 10-Q · filed 2026-08-07 | -$171.00K derived: sum of 3 quarters · filed 2026-08-07 | $102.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $27.00K 10-Q · filed 2026-05-15 | -$162.00K derived: sum of 2 quarters · filed 2026-05-15 | $111.00K derived: sum of 3 quarters · filed 2026-05-15 | $26.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $84.00K derived: sum of 2 quarters · filed 2026-03-27 | -$1.00K derived: sum of 3 quarters · filed 2026-03-27 | -$93.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $273.00K 10-Q · filed 2025-11-17 | $188.00K derived: sum of 2 quarters · filed 2025-11-17 | $96.00K 10-Q · filed 2025-11-17 | $497.00K derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$85.00K 10-Q · filed 2025-08-14 | -$177.00K 10-Q · filed 2025-08-14 | $224.00K derived: sum of 3 quarters · filed 2025-08-14 | -$86.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$92.00K 10-Q · filed 2025-05-15 | $309.00K derived: sum of 2 quarters · filed 2025-05-15 | -$1.00K derived: sum of 3 quarters · filed 2025-05-15 | -$95.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $401.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $91.00K derived: sum of 2 quarters · filed 2025-03-27 | -$3.00K derived: sum of 3 quarters · filed 2025-03-27 | $200.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | -$310.00K 10-Q · filed 2024-11-14 | -$404.00K derived: sum of 2 quarters · filed 2024-11-14 | -$201.00K 10-Q · filed 2024-11-14 | -$111.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$94.00K 10-Q · filed 2024-08-14 | $109.00K 10-Q · filed 2024-08-14 | $199.00K derived: sum of 3 quarters · filed 2024-08-14 | -$166.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $203.00K 10-Q · filed 2024-05-15 | $293.00K derived: sum of 2 quarters · filed 2024-05-15 | -$72.00K derived: sum of 3 quarters · filed 2024-05-15 | -$542.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$275.00K derived: sum of 2 quarters · filed 2024-04-01 | -$745.00K derived: sum of 3 quarters · filed 2024-04-01 | -$1.68M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$365.00K 10-Q · filed 2023-11-14 | -$835.00K derived: sum of 2 quarters · filed 2023-11-14 | -$1.77M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | -$470.00K 10-Q · filed 2023-08-14 | -$1.40M 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$934.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$201.00K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | $219.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |